Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.

Annals of the rheumatic diseases(2023)

引用 0|浏览28
暂无评分
摘要
These results suggest that dupilumab may be effective in treating patients with EGPA-related ENT manifestations. However, EGPA flares occurred in one-third of patients and were preceded by eosinophilia in 88%, suggesting that caution is required.
更多
查看译文
关键词
Systemic vasculitis, Immune System Diseases, Biological Therapy, Autoimmune Diseases, Therapeutics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要